Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study

Fig. 2

Random Forest (A) and XGBoost (B) importance plots for predicting annualized changes in LLACS. Only the top four-five variables by importance that are predictive of LLACS progression are reported. eGFR, estimated glomerular filtration rate; LLACS, lower limb arterial calcification score

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840